Zacks Research Has Bullish Forecast for BMRN Q4 Earnings
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Zacks Research boosted their Q4 2025 earnings per share (EPS) estimates for BioMarin Pharmaceutical in a research note issued on Monday, February 17th. Zacks Research analyst S. Ganoria now anticipates that the biotechnology company will earn $0.67 per share for the quarter, up from their prior forecast […]
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Zacks Research boosted their Q4 2025 earnings per share (EPS) estimates for BioMarin Pharmaceutical in a research note issued on Monday, February 17th. Zacks Research analyst S. Ganoria now anticipates that the biotechnology company will earn $0.67 per share for the quarter, up from their prior forecast […]
